Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients
2009 · Arthritis Research & Therapy · 101 citations
https://doi.org/10.1186/ar2868
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
161
Papers
2.7K
Citations
27
h-index
49
i10-index
Sandrine Guis is an academic researcher from Inserm. The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & Spondyloarthritis Studies and Treatments & Inflammatory Myopathies and Dermatomyositis. The author has an h-index of 27, co-authored 137 publications.
ORCID: 0000-0003-1023-1526https://doi.org/10.1186/ar2868
https://doi.org/10.1186/ar1678
https://doi.org/10.1186/ar1584
Click to start Chat